Jane Street’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$544K Sell
194,868
-4,471
-2% -$13.6K ﹤0.01% 7848
2025
Q4
$829K Buy
199,339
+184,663
+1,258% +$972K ﹤0.01% 6538
2025
Q3
$62.2K Sell
14,676
-733,976
-98% -$2.76M ﹤0.01% 10288
2025
Q2
$1.58M Buy
+748,652
New +$1.12M ﹤0.01% 4807
2025
Q1
Hold
0
9831
2024
Q4
Hold
0
9837
2024
Q2
Sell
-36,785
Closed -$87.9K 9669
2024
Q1
$87.9K Buy
36,785
+3,016
+9% +$5.71K ﹤0.01% 8572
2023
Q4
$56.1K Buy
+33,769
New +$65.5K ﹤0.01% 8757
2023
Q2
Sell
-40,522
Closed -$85.1K 8981
2023
Q1
$85.1K Buy
40,522
+5,124
+14% +$8.27K ﹤0.01% 8296
2022
Q4
$40K Buy
+35,398
New +$47.2K ﹤0.01% 8437
2022
Q1
Hold
0
10568
2021
Q4
Hold
0
10361
2021
Q3
Sell
-11,133
Closed -$37.7K 10240
2021
Q2
$36K Buy
+11,133
New +$39.6K ﹤0.01% 9564
2019
Q4
Sell
-23,849
Closed -$88K 5311
2019
Q3
$88K Buy
+23,849
New +$86.2K ﹤0.01% 4812
2019
Q2
Sell
-22,029
Closed -$113K 5351
2019
Q1
$113K Buy
+22,029
New +$106K ﹤0.01% 4758
2018
Q3
Sell
-14,369
Closed -$91K 5338
2018
Q2
$91K Buy
+14,369
New +$70K ﹤0.01% 4750
2014
Q3
Sell
-19,096
Closed -$264K 2737
2014
Q2
$264K Buy
19,096
+5,745
+43% +$71.5K 0.01% 1943
2014
Q1
$204K Buy
+13,351
New +$190K ﹤0.01% 2351
2013
Q4
Sell
-10,076
Closed -$100K 2554
2013
Q3
$100K Buy
+10,076
New +$68K ﹤0.01% 2547

Other funds holding GALT